Follow-The-Filings

Security · featured owners

AVBP Arrivent Biopharma Inc.

Health Care COM Equity among managers we track

AVBP (Arrivent Biopharma Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 24 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,2.02,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
424B5
8-K 8.01,9.01
DEFA14A
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-K
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
8-K 1.01,8.01,9.01
424B5
424B5
8-K 7.01,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Jun 18, 2026 · 4 forms
4 Period Feb 2, 2026 · 5 forms
4 Period Dec 10, 2025
4 Period Jul 11, 2025
4 Period Jun 18, 2025 · 4 forms
4 Period Apr 28, 2025

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Net income -$80.49M -$166.31M

Balance sheet

Metric FY2024 FY2025
Total current assets $226.98M $332.9M
Total non-current assets * $47.96M $0.272M
Total assets $274.94M $333.17M
Total current liabilities $17.27M $25.94M
Total non-current liabilities * $14,000 $0.00
Total equity $257.65M $307.22M

Cash flow

Metric FY2024 FY2025
Cash from operations -$70.21M -$160.59M
Cash from investing -$192.46M -$71.23M
Cash from financing $186.58M $203.06M
Net change in cash -$76.1M -$28.75M

Ownership over time

filing count by report period · click a bar for that quarter’s holders